False about Cytarabine is
**Core Concept**
Cytarabine is a chemotherapy medication primarily used to treat various types of leukemia and lymphoma. It belongs to the class of nucleoside analogs, which interfere with DNA synthesis, thereby inhibiting cancer cell growth.
**Why the Correct Answer is Right**
Cytarabine works by being phosphorylated to its triphosphate form, which then acts as a false base in DNA synthesis, causing chain termination. The correct answer is not provided in the options, so we will evaluate the distractors below.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because cytarabine is indeed used in the treatment of leukemia and lymphoma, but it's not the only indication. It's also used in the treatment of other cancers like ovarian cancer and breast cancer.
**Option B:** Incorrect because cytarabine is a nucleoside analog, not a nucleotide analog. Nucleoside analogs are modified nucleosides that interfere with DNA synthesis.
**Option C:** Incorrect because cytarabine's mechanism of action involves the inhibition of DNA polymerase, not DNA topoisomerase. DNA topoisomerase is a different enzyme that is targeted by other chemotherapeutic agents.
**Clinical Pearl / High-Yield Fact**
Cytarabine's dose and schedule can be adjusted based on the specific type of cancer being treated and the patient's overall health. It's essential to monitor patients for potential side effects like nausea, vomiting, and bone marrow suppression.
**Correct Answer: Not Provided**